| Dr James David Bruckner, MD | |
|
1231 116th Ave Ne, Suite 750, Bellevue, WA 98004-3804 | |
| (425) 455-3600 | |
| (425) 455-3920 |
| Full Name | Dr James David Bruckner |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 40 Years |
| Location | 1231 116th Ave Ne, Bellevue, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154392942 | NPI | - | NPPES |
| 0180310 | Other | WA | L & I |
| G8901824 | Other | WA | MEDICARE EMRI |
| G8801228 | Other | WA | MEDICARE POSM |
| P0154442 | Other | WA | MEDICARE RR KING CO. |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD00027573 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Overlake Hospital Medical Center | Bellevue, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Proliance Surgeons Inc Ps | 8527972900 | 388 |
News Archive
A new paper in the journal Reviews in Medical Virology provides a perspective on current vaccine development strategies and tools, which may allow the production of safe and effective vaccines.
Pfizer Inc. presented today the results from a Phase 3 study investigating immunogenicity, tolerability and safety of Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) in adults 18 to 49 years of age.
A new study provides neurobiological evidence for dysfunction in the neural circuitry underlying emotion regulation in people with insomnia, which may have implications for the risk relationship between insomnia and depression.
Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.
The German Federal Ministry of Health has awarded more than one million euros in research and development funding for the efficient production of an important cancer diagnostic agent at the research neutron source FRM II. In a 2009 feasibility study, the Technische Universitaet Muenchen demonstrated that due to the high neutron flux the neutron source in Garching can produce about half of the European demand of the radioisotope molybdenum-99.
› Verified 5 days ago
| Entity Name | Proliance Surgeons Inc Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023170313 PECOS PAC ID: 8527972900 Enrollment ID: O20031119000128 |
News Archive
A new paper in the journal Reviews in Medical Virology provides a perspective on current vaccine development strategies and tools, which may allow the production of safe and effective vaccines.
Pfizer Inc. presented today the results from a Phase 3 study investigating immunogenicity, tolerability and safety of Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) in adults 18 to 49 years of age.
A new study provides neurobiological evidence for dysfunction in the neural circuitry underlying emotion regulation in people with insomnia, which may have implications for the risk relationship between insomnia and depression.
Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.
The German Federal Ministry of Health has awarded more than one million euros in research and development funding for the efficient production of an important cancer diagnostic agent at the research neutron source FRM II. In a 2009 feasibility study, the Technische Universitaet Muenchen demonstrated that due to the high neutron flux the neutron source in Garching can produce about half of the European demand of the radioisotope molybdenum-99.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James David Bruckner, MD 805 Madison St, Suite 901, Seattle, WA 98104-1172 Ph: (206) 264-8100 | Dr James David Bruckner, MD 1231 116th Ave Ne, Suite 750, Bellevue, WA 98004-3804 Ph: (425) 455-3600 |
News Archive
A new paper in the journal Reviews in Medical Virology provides a perspective on current vaccine development strategies and tools, which may allow the production of safe and effective vaccines.
Pfizer Inc. presented today the results from a Phase 3 study investigating immunogenicity, tolerability and safety of Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) in adults 18 to 49 years of age.
A new study provides neurobiological evidence for dysfunction in the neural circuitry underlying emotion regulation in people with insomnia, which may have implications for the risk relationship between insomnia and depression.
Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.
The German Federal Ministry of Health has awarded more than one million euros in research and development funding for the efficient production of an important cancer diagnostic agent at the research neutron source FRM II. In a 2009 feasibility study, the Technische Universitaet Muenchen demonstrated that due to the high neutron flux the neutron source in Garching can produce about half of the European demand of the radioisotope molybdenum-99.
› Verified 5 days ago
Michael J Battaglia Ii, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1427 116th Ave Ne, Bellevue, WA 98004 Phone: 425-462-9800 Fax: 425-454-9143 | |
Dr. Lance S Ho, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 | |
Dean S Ricketts, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1231 116th Ave Ne, Suite 100, Bellevue, WA 98004 Phone: 425-454-5344 Fax: 425-462-0763 | |
Dr. Thomas E Trumble, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1200 112th Ave Ne Ste C210, Bellevue, WA 98004 Phone: 425-999-3580 Fax: 425-999-3122 | |
Mary Kathryn Thayer, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3101 Northup Way Ste 201, Bellevue, WA 98004 Phone: 425-455-3600 Fax: 425-455-3920 | |
Alan Burchard Brown, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1427 116th Ave Ne, Bellevue, WA 98004 Phone: 425-462-9800 Fax: 425-454-9143 | |
Matthew Lawrence Lyons, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3700 Fax: 425-502-3701 |